Senseonics (NYSE:SENS) today priced stock and debt offerings worth a total of at least $107 million.
Germantown, Md.-based Senseonics, which developed the Eversense implantable CGM, announced the offerings yesterday.
Get the full story at our sister site, Drug Delivery Business News